As of 2024-12-13, the Relative Valuation of Boule Diagnostics AB (BOUL.ST) is (36.39) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 8.70 SEK, the upside of Boule Diagnostics AB based on Relative Valuation is -518.3%.
The range of the Relative Valuation is (71.29) - 20.73 SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 25.8x | 16.5x |
| Forward P/E multiples | 21.8x - 33.8x | 28.6x |
| Fair Price | (71.29) - 20.73 | (36.39) |
| Upside | -919.4% - 138.3% | -518.3% |
| Date | P/E |
| 2024-12-09 | -1.55 |
| 2024-12-06 | -1.61 |
| 2024-12-05 | -1.61 |
| 2024-12-04 | -1.60 |
| 2024-12-03 | -1.59 |
| 2024-12-02 | -1.63 |
| 2024-11-29 | -1.44 |
| 2024-11-28 | -1.42 |
| 2024-11-27 | -1.28 |
| 2024-11-26 | -1.35 |
| 2024-11-25 | -1.28 |
| 2024-11-22 | -1.35 |
| 2024-11-21 | -1.23 |
| 2024-11-20 | -1.25 |
| 2024-11-19 | -1.24 |
| 2024-11-18 | -1.23 |
| 2024-11-15 | -1.29 |
| 2024-11-14 | -1.25 |
| 2024-11-13 | -1.22 |
| 2024-11-12 | -1.24 |
| 2024-11-11 | -1.33 |
| 2024-11-08 | -1.31 |
| 2024-11-07 | -1.28 |
| 2024-11-06 | -1.27 |
| 2024-11-05 | -1.32 |
| 2024-11-04 | -1.30 |
| 2024-11-01 | -1.29 |
| 2024-10-31 | -1.35 |
| 2024-10-30 | -1.42 |
| 2024-10-29 | -1.31 |
| 2024-10-28 | -1.31 |
| 2024-10-25 | -1.36 |
| 2024-10-24 | -1.29 |
| 2024-10-23 | -1.40 |
| 2024-10-22 | -1.26 |
| 2024-10-21 | -1.28 |
| 2024-10-18 | -1.31 |
| 2024-10-17 | -1.32 |
| 2024-10-16 | -1.35 |
| 2024-10-15 | -1.38 |
| 2024-10-14 | -1.38 |
| 2024-10-11 | -1.35 |
| 2024-10-10 | -1.40 |
| 2024-10-09 | -1.40 |
| 2024-10-08 | -1.52 |
| 2024-10-07 | -1.55 |
| 2024-10-04 | -1.56 |
| 2024-10-03 | -1.59 |
| 2024-10-02 | -1.61 |
| 2024-10-01 | -1.65 |